TY  - GEN
AU  - Gallien,Sébastien
AU  - Braun,Joséphine
AU  - Delaugerre,Constance
AU  - Charreau,Isabelle
AU  - Reynes,Jacques
AU  - Jeanblanc,François
AU  - Verdon,Renaud
AU  - de Truchis,Pierre
AU  - May,Thierry
AU  - Madelaine-Chambrin,Isabelle
AU  - Aboulker,Jean-Pierre
AU  - Molina,Jean-Michel
TI  - Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial
SN  - 1460-2091
PY  - 2011///1014
KW  - Adult
KW  - Alanine Transaminase
KW  - blood
KW  - CD4 Lymphocyte Count
KW  - Drug Resistance, Multiple, Viral
KW  - Endpoint Determination
KW  - Enfuvirtide
KW  - Female
KW  - France
KW  - Genotype
KW  - HIV Envelope Protein gp41
KW  - therapeutic use
KW  - HIV Fusion Inhibitors
KW  - HIV Infections
KW  - HIV Integrase Inhibitors
KW  - adverse effects
KW  - HIV-1
KW  - Humans
KW  - Male
KW  - Microbial Sensitivity Tests
KW  - Middle Aged
KW  - Peptide Fragments
KW  - Pilot Projects
KW  - Prospective Studies
KW  - Pyrrolidinones
KW  - RNA, Viral
KW  - Raltegravir Potassium
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/jac/dkr269
ER  -